Thieme and ChemRxiv have announced an integration allowing researchers who post preprints on ChemRxiv to seamlessly submit their manuscripts to SYNLETT, a renowned peer-reviewed journal specializing in chemical synthesis research. This collaboration streamlines the path from preprint sharing to formal publication, supporting rapid dissemination of scientific findings.
ChemRxiv, a free platform for submitting and archiving preprints in the chemical sciences, enables researchers to share their work globally, establish priority, and receive early feedback before peer review. With SYNLETT now accessible through ChemRxiv’s Direct Journal Transfer process, authors benefit from a simplified submission pathway to a journal recognized for its focus on cutting-edge developments in chemical synthesis.
SYNLETT also offers an innovative Select Crowd Review (SCR) option alongside traditional peer review, reducing review time to as little as four days, ensuring swift publication of high-impact research.
Thieme, known for its digital solutions in medicine and chemistry, emphasizes the importance of accelerating the publication process while maintaining rigorous quality standards. The integration with ChemRxiv reinforces Thieme’s commitment to advancing research communication and supporting scientists in disseminating their work efficiently.
Researchers can log into ChemRxiv to share their findings and take advantage of the Direct Journal Transfer process, opening doors to rapid publication and global visibility.
Click here to read the original press release.
